Logjam breaks on GATT repair

WASHINGTON - The House last week brushed off a major challenge to patent legislation that is strongly supported by the biotechnology industry.

The House voted 227-178 to reject Rep. Dana Rohrabacher's (R-Calif.) substitute for H.R. 400, the 21st

Read the full 371 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE